AzTrials
AzTrials

Maternal Child HealthNCT04313348

Patient-centered Mobile Technology Interventions to Improve Maternal Health in Uganda

A study testing eMobilize-Uganda application in people with Maternal Child Health, run by Mbarara University of Science and Technology at 1 site in Uganda.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ugandan women and their children suffer from high maternal mortality (360 for every 100,000 women) and perinatal mortality (41 deaths per 1000 births). Only 58% of pregnant women attend at least 4 Antenatal Care (ANC) visits (of the recommended 8) and only 70% deliver with a skilled attendant. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Maternal Child Health
What is being tested?
eMobilize-Uganda application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
170 participants
Where
1 siteUganda
Study dates
1 Aug 2020to 1 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • age 18 years and older, living in Mbarara district (within 20 km of the antenatal clinic), owning a cell phone for personal use with reliable cellular phone reception, able to give informed consent, and willing to identify at least two social supporters.

Who cannot join

  • women with known high risk pregnancies classified as; hypertensive, history of gestational diabetes, history of pre-eclampsia or other severe birth complications.

Trial locations and contacts

1 site in 1 country.

Uganda1 site
  • Mbarara Regional Referral Hospital

    Mbarara, 0256

Other trials in Uganda

About this study

Ugandan women and their children suffer from high maternal mortality (360 for every 100,000 women) and perinatal mortality (41 deaths per 1000 births). Only 58% of pregnant women attend at least 4 Antenatal Care (ANC) visits (of the recommended 8) and only 70% deliver with a skilled attendant. The design and evaluation of patient-centered, interventions to engage social support and improve utilization of ANC and skilled delivery services, with an overarching goal of improving maternal child health in lower-resourced settings.

Read the detailed description

Aim 3 Overview. The investigator will pilot test the intervention to assess feasibility, acceptability and preliminary efficacy to improve ANC utilization and skilled births. Randomization of 120 adult pregnant women of gestational ages ≤ 20 weeks of amenorrhea to standard of care (information giving) (n=40), mHealth SMS intervention (n=40), and mHealth SMS intervention plus mHealth social support engagement (n=40) will be done. Feasibility and acceptability will be primary outcomes. ANC visit attendance and proportion of births attended by a skilled provider will be collected for power estimates for future studies, designed to test the efficacy of the intervention.

Study Setting: This study will take place at Mbarara Regional Referral Hospital, Mbarara, Uganda. Participants will be recruited through the antenatal Clinic, which receives over 30,000 women attending routine antenatal care annually (both normal and high-risk pregnancies). The hospital conducts over 10,000 deliveries per year. Maternity services, including delivery, are largely provided free of charge through public hospitals and health centers.

Study Procedures: Study participants randomized to either of the intervention arms will receive the CommCare application (eMobilize-Uganda) that will include message content and information developed in aim 2. Participants will get adequate instructions on how to use the application to retrieve information. The times and length for individual login sessions will be recorded and transmitted to the server. The smart phone will serve as a gateway to display and visualize intended message content in form of voice, video or text. Once visualization is complete, login data will then be transmitted from the gateway device to a secure web-based server for storage or further viewing through a web portal following a prompt to confirm completion of viewing session and log out to enable submission of data to the server for review via password access of any device that can access the web. Log-ins during periods of inadequate cellular reception will be stored for later transmission. Study participants will be given solar chargers and reminded to charge the phones as needed during enrolment. SMS will also be sent via CommCare. Application log-ins will be considered as proxies for accessing information to alter existing predisposing factors (such as negative health beliefs) that could enable and improve perceived need to seek care. Engagement of social networks will be to enable service utilization and motivate individuals to seek care through regular scheduled SMS reminders.

Randomization: Prior to study initiation, a random number generator will be used to determine arm assignment for study participants. Research assistants will be informed of the arm assignment at the time of participant enrolment. Study arms will be defined as follows: Arm 1: will only receive the standard of care (information giving), as a "Control arm". Study participants in this arm will receive no SMS reminders nor social supporter notifications. Arm 2, also called "Scheduled SMS arm": Will receive an mHealth intervention targeted to the study participant (such as health information on an eMobilize-Uganda application or messaging and SMS reminders, or a voice call if at high risk). A weekly SMS reminder on the impending ANC appointment and expected date of delivery at their preferred time and day of the week will be sent to study participants. The content of the SMS reminders will be customized and determined by everyone at enrolment. If the participant has no preference, we will suggest "This is your ANC visit reminder, encouraging you to attend". This technology is already integrated and running in Uganda via the Yo! Uganda Gateway. Arm 3: Will receive an mhealth intervention targeted to the participant plus an intervention targeted to engage the social supporter. Study participants will receive health information and SMS reminders same as those of "scheduled SMS arm" above + weekly SMS notifications to the 2 pre-identified social supporters. Notifications will bear upcoming ANC visit and delivery due date for the study participant they are supporting for all the study follow-up period (also called the "social support engagement arm"). Social supporters will be able to personalize the SMS content at enrolment. They will be advised to assist study participants with any problems that may affect ANC attendance or facility delivery, but will not be given specific instructions on what to do.

Data collection: will be performed in the local language, Runyankole. Quantitative questionnaire data will be collected from both study participants and their social supporters at enrolment on the following topics: socio-demographic characteristics: maternal age, gravidity, parity, gestational age, prenatal and antepartum high-risk morbidities, depression, health, food insecurity, alcohol use, social support, reproductive health history, perceptions on pregnancy and delivery. Reports of social support received by study participants will not specify the source as it could occur from outside the dyad studied here. Another questionnaire with closed and open-ended questions that explores specific role of social supporter in study participant's life and pregnancy during study period, communication or contact with study participant and what things they talked about or did together, the type of voluntary and requested help or support given to or received by the study participant during pregnancy towards improving her experience and attendance of scheduled ANC visits, challenges and experiences to social support will be administered at exit. At exit (within 2-4 weeks postpartum), a survey will be administered to assess the understanding, likes, dislikes and challenges, perceived usefulness, ease of use, actual use, barriers of the mHealth-based, social support intervention model aimed at improving utilization of maternity services. Other delivery outcomes (having a still birth and or maternal death), women responding to an SMS notification, number of log-ins to CommCare application, time between scheduled and actual ANC review, birth preparedness, mode of delivery, initiation of breastfeeding, 1 and 5-minute Apgar scores (if known), neonatal weight, need for neonatal or maternal resuscitation, use of assisted ventilation by mother or neonate, hospital stay and any other reported maternal or neonatal complications will be documented. ANC attendance and delivery details will be collected by reviewing the routinely provided ANC cards and postnatal discharge forms provided to confirm self-reports. Women will be followed for at least 6 months and will receive the standard routine care provided at the maternity centers. Data will be collected using an online database that will be developed in CommCare to improve data completeness, management and quality control monitoring. Data entry verification will include algorithms that automatically check completed forms for missing, out-of-range, or inconsistent values before a form can be saved on the website. Additionally, exit in-depth interviews with 30 study participants (15 from each intervention arm) and 10 social supporters will also be conducted to explore the patterns of social support and mechanisms of effect of the intervention. This selection will be based on the study participant's prenatal and perinatal outcomes, type of social support, and study participant characteristics. These interviews with be carried out within the 2-4 weeks postpartum. Interview guides will be developed with guidance from observed quantitative results, as well as two theoretical frameworks; the Unified Theory of Acceptance and Use of Technology (UTAUT) and the HUM. These interviews will last for an hour. To maximize data quality, we will ask interviewees to describe actual experiences and events wherever possible. Examples of interview topics will be: (1) Experiences: descriptions of particular experiences with the telephone and SMS type (the most recent reminder or notification, or telephone received and what happened as a result, the most or least helpful/useful reminder, notification or telephone received and what happened as a result, (2) acceptance: advantages and disadvantages of the mHealth intervention, ease of use, its ability to request or get support as needed, guidance on what to do, SMS type; problems experienced with the intervention; ideas for improvement, intention to use in future (3) consequences: changes or lack of changes resulting from use of mHealth intervention and SMS type; (4) comparisons and attitude: differences, similarities and attitude across the SMS types and other interventions.

Quantitative data analysis. I will use summary statistics to compare the health-related and socio-demographic data for both study participants and social supporters between arms. We will verify the technical function of the intervention with the following statistics: Number of successful application log-ins, number of SMS received by the participant over number of SMS anticipated per protocol, number and type of technical problems encountered, number of SMS notifications responded to by the social supporters, number of women responding to an SMS reminder or notification, time between scheduled and actual ANC review. I will assess acceptability by describing the length of application log-ins, engagement of the application, number of likes or dislikes for the intervention and reported ease of use. Although not powered to detect significant differences, I will preliminarily compare maternal health outcomes between the three study arms to consider power requirements for future larger intervention studies. These outcomes will include attendance of at least 4 ANC visits, delivery in presence of skilled personnel, still birth, and maternal death. To do so, I will fit univariable and multivariable Poisson regression models. The multivariable model will comprise of those baseline variables whose p-value will be <0.1 from the univariable model. A study arm will be included in all regression models to control for any potential differences in ANC or delivery outcomes. The study participant's social support and the social supporter's characteristics (type of relationship, income status, food insecurity, alcohol use, gender, previous obstetric history, delivery status, place of delivery, morbidity/health status, alcohol use, gender and involvement in any health or community group will be assessed as potential predictors of ANC and delivery outcomes based on potential impact on the relationship and instrumental support for the study participant. Study participant's social support will be divided into instrumental and emotional support. Interactions between instrumental support and food insecurity using the recommended Household Food Insecurity Access Scale (HFIAS) and income status will also be assessed because of the low resource nature of this setting which may impede the ability to provide physical support despite the intension to do so. Data analysis will be conducted in STATA version 13.

Qualitative data analysis: In-depth interviews will be digitally recorded and transcribed. The goal of the interviews will be to document the participants' experiences of the mHealth-based social support intervention, mechanisms of effect and or contextual explanations observed within the quantitative results, acceptance and patterns of social support. Qualitative analysis will be inductive and categories will be derived from the different social supporter/ study participant interviews and open-ended questions. These responses will be transcribed into English and coded using Atlas.ti. Categories will then be developed and presented with illustrative quotes from study participant and social supporter data to explain the role, type, challenges, acceptance and experience of the intervention during the study period.

Being tested
eMobilize-Uganda application

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • eMobilize-Uganda applicationBehavioural

    Also called Same as above

    Arm 1 is the "Control arm". Participants will receive no SMS reminders nor social supporter notifications. Arm 2, "Scheduled SMS arm": Will receive an mHealth intervention targeted to the study participant (such as health information on an eMobilize-Uganda CommCare application or messaging and SMS reminders, or a voice call if at high risk). A weekly SMS reminder on the impending ANC appointment and expected date of delivery will be sent to participants. The content of the SMS reminders will be customized at enrolment. Arm 3 "social support engagement arm": Will receive an mhealth intervention targeted to the participant plus an intervention targeted to engage the social supporter. Study participants will receive health information through the eMobilize-Uganda CommCare application or messaging + weekly SMS reminders + weekly SMS notifications to the 2 pre-identified social supporters. Notifications will bear upcoming ANC visit and delivery due date for all the study follow-up period.

Study groups in NCT04313348
Study groupRoleWhat they receive
Control ArmActive comparatorStudy participants in this arm will receive no SMS reminders nor social supporter notifications.
Receives: Behavioral: eMobilize-Uganda application
Intervention Arm 1ExperimentalParticipants will receive an mHealth intervention targeted to the study participant (such as health information on an eMobilize-Uganda application or messaging and SMS reminders, or a voice call if at high risk). A weekly SMS reminder on the impending ANC appointment and expected date of delivery at their preferred time and day of the week will be sent to study participants. The content of the SMS reminders will be customized and determined by each individual at enrollment. If the participant has no preference, we will suggest "This is your ANC visit reminder, encouraging you to attend". This technology is already integrated and running in Uganda via the Yo! Uganda Gateway.
Receives: Behavioral: eMobilize-Uganda application
Intervention Arm 2ExperimentalParticipants will receive an mhealth intervention targeted to the participant plus an intervention targeted to engage the social supporter. Study participants will receive health information and SMS reminders same as those of "scheduled SMS arm" above + weekly SMS notifications to the 2 pre-identified social supporters. Notifications will bear upcoming ANC visit and delivery due date for the study participant they are supporting for all the study follow-up period (also called the "social support engagement arm"). Social supporters will be able to personalize the SMS content at enrollment. They will be advised to assist study participants with any problems that may affect ANC attendance or facility delivery, but will not be given specific instructions on what to do.
Receives: Behavioral: eMobilize-Uganda application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of emobilize application

    Questionnaire to assess ability to utilize emobilize application, to open received message, read and understand it

    Measured: 5 months

  2. Acceptability of emobilize application

    Acceptability will be measured using the Technology Acceptance Model (TAM) to assess ease-of-use, motivation, social influence, perceived control, attitude towards use of the technology, and its usefulness

    Measured: 5 months

Secondary outcomes (2)
  1. ANC attendance

    Number of women attending at least 4 ANC visits

    Measured: 9months

  2. Skilled births

    Proportion of births attended by skilled providers

    Measured: 9months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2020
  2. Study start1 Aug 2020
  3. Primary completion1 Feb 2022
  4. Study completion1 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
170 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04313348
Sponsor's protocol ID
MUST 13/09-18
Status last verified
Apr 2022
First submitted
10 Mar 2020
Last updated
5 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The protocol, statistical analysis plan, informed consent forms and clinical study report will be made available after the study

Publications

  • Atukunda EC, Siedner MJ, Obua C, Musiimenta A, Ware NC, Mugisha S, Najjuma JN, Mugyenyi GR, Matthews LT. Evaluating the Feasibility, Acceptability, and Preliminary Efficacy of SupportMoms-Uganda, an mHealth-Based Patient-Centered Social Support Intervention to Improve the Use of Maternity Services Among Pregnant Women in Rural Southwestern Uganda: Randomized Controlled Trial. JMIR Form Res. 2023 Mar 2;7:e36619. doi: 10.2196/36619.

    PubMed 36862461

Questions about this trial

What is this clinical trial studying?

A study testing eMobilize-Uganda application in people with Maternal Child Health, run by Mbarara University of Science and Technology at 1 site in Uganda.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Uganda. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of emobilize application (time frame: 5 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04313348, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in